{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:38:15Z","timestamp":1792690695612,"version":"4.5.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>\n                    The efficacy of antibiotics and other antimicrobial agents in combating bacterial infections faces a grave peril in the form of antimicrobial resistance (AMR), an exceedingly pressing global health issue. The emergence and dissemination of drug-resistant bacteria can be attributed to the rampant overuse and misuse of antibiotics, leading to dire consequences such as organ failure and sepsis. Beyond the realm of individual health, the pervasive specter of AMR casts its ominous shadow upon the economy and society at large, resulting in protracted hospital stays, elevated medical expenditures, and diminished productivity, with particularly dire consequences for vulnerable populations. It is abundantly clear that addressing this ominous threat necessitates a concerted international endeavor encompassing the optimization of antibiotic deployment, the pursuit of novel antimicrobial compounds and therapeutic strategies, the enhancement of surveillance and monitoring of resistant bacterial strains, and the assurance of universal access to efficacious treatments. In the ongoing struggle against this encroaching menace, phage-based therapies, strategically tailored to combat AMR, offer a formidable line of defense. Furthermore, an alluring pathway forward for the development of vaccines lies in the utilization of virus-like particles (VLPs), which have demonstrated their remarkable capacity to elicit a robust immune response against bacterial infections. VLP-based vaccinations, characterized by their absence of genetic material and non-infectious nature, present a markedly safer and more stable alternative to conventional immunization protocols. Encouragingly, preclinical investigations have yielded promising results in the development of VLP vaccines targeting pivotal bacteria implicated in the AMR crisis, including\n                    <jats:italic>Salmonella, Escherichia coli,<\/jats:italic>\n                    and\n                    <jats:italic>Clostridium difficile<\/jats:italic>\n                    . Notwithstanding the undeniable potential of VLP vaccines, formidable challenges persist, including the identification of suitable bacterial markers for vaccination and the formidable prospect of bacterial pathogens evolving mechanisms to thwart the immune response. Nonetheless, the prospect of VLP-based vaccines holds great promise in the relentless fight against AMR, underscoring the need for sustained research and development endeavors. In the quest to marshal more potent defenses against AMR and to pave the way for visionary innovations, cutting-edge techniques that incorporate RNA interference, nanomedicine, and the integration of artificial intelligence are currently under rigorous scrutiny.\n                  <\/jats:p>","DOI":"10.3389\/fmicb.2023.1270018","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T03:51:08Z","timestamp":1701316268000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Crisis averted: a world united against the menace of multiple drug-resistant superbugs -pioneering anti-AMR vaccines, RNA interference, nanomedicine, CRISPR-based antimicrobials, bacteriophage therapies, and clinical artificial intelligence strategies to safeguard global antimicrobial arsenal"],"prefix":"10.3389","volume":"14","author":[{"given":"Umar","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawal Alies","family":"Insaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Zahid","family":"Piracha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nouman","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azka","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umer Ali","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahmeer","family":"Fida Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Shayan","family":"Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seneen","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyeen","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzammil Hasan","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/antibiotics12030523","article-title":"Artificial intelligence for antimicrobial resistance prediction: challenges and opportunities towards practical implementation","volume":"12","author":"Ali","year":"2023","journal-title":"Antibiotics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"174178","DOI":"10.1016\/j.ejphar.2021.174178","article-title":"siRNA: mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3855\/jidc.13467","article-title":"Antibiotic usage and resistance in Mexico: an update after a decade of change","volume":"15","author":"Amabile-Cuevas","year":"2021","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1128\/microbiolspec.ARBA-0011-2017","article-title":"Molecular methods for detection of antimicrobial resistance","volume":"5","author":"Anjum","year":"2017","journal-title":"Microbiol Spectr."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13756-020-00795-6","article-title":"CRISPR-Cas system: a potential alternative tool to cope antibiotic resistance","volume":"9","author":"Aslam","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"113720","DOI":"10.1016\/j.biopha.2022.113720","article-title":"Phage-tail-like bacteriocins as a biomedical platform to counter anti-microbial resistant pathogens","volume":"155","author":"Bhattacharjee","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mib.2017.08.005","article-title":"Using CRISPR-Cas systems as antimicrobials","volume":"37","author":"Bikard","year":"2017","journal-title":"Curr. Opin. Microbiol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drup.2014.02.001","article-title":"Antimicrobial resistance among Enterobacteriaceae in South America: history, current dissemination status and associated socioeconomic factors","volume":"17","author":"Bonelli","year":"2014","journal-title":"Drug Resist. Updat."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijid.2019.10.005","article-title":"Impact of vaccines on antimicrobial resistance","volume":"90","author":"Buchy","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"n180","DOI":"10.1136\/bmj.n180","article-title":"International collaboration and COVID-19: what are we doing and where are we going?","volume":"372","author":"Bump","year":"2021","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"820572","DOI":"10.3389\/fmicb.2022.820572","article-title":"Phage revolution against multidrug-resistant clinical pathogens in Southeast Asia","volume":"13","author":"Carascal","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2166\/wh.2022.146","article-title":"A review of antibiotic resistance among Campylobacter species in human, animal, and water sources in South Africa: a one health approach","volume":"21","author":"Chibwe","year":"2023","journal-title":"J. Water Health"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14787210.2020.1705155","article-title":"Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction","volume":"18","author":"Coates","year":"2020","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/1467-8489.12450","article-title":"An economic lens to understanding antimicrobial resistance: disruptive cases to livestock and wastewater management in Australia","volume":"65","author":"Cooper","year":"2021","journal-title":"Aust. J. Agric. Resour. Econ."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","article-title":"Origins and evolution of antibiotic resistance","volume":"74","author":"Davies","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.2147\/IDR.S369023","article-title":"The phenomenon of antibiotic resistance in the polar regions: an overview of the global problem","volume":"16","author":"Depta","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bcp.2016.12.005","article-title":"Antibiotic resistance: A current epilogue","volume":"134","author":"Dodds","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/pharmaceutics12020142","article-title":"Nanomedicine fight against antibacterial resistance: an overview of the recent pharmaceutical innovations","volume":"12","author":"Eleraky","year":"2020","journal-title":"Pharmaceutics"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1080\/10408398.2015.1077192","article-title":"Antimicrobial resistance: a global emerging threat to public health systems","volume":"57","author":"Ferri","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1089\/mdr.2017.0383","article-title":"Antibiotic resistance in food animals in Africa: a systematic review and meta-analysis","volume":"24","author":"Founou","year":"2018","journal-title":"Microb. Drug Resist."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.11604\/pamj.2020.35.37.18323","article-title":"Antibiotic resistance patterns in human, animal, food and environmental isolates in Ghana: a review","volume":"35","author":"Garc\u00eda-Vello","year":"2020","journal-title":"Pan Afr. Med. J."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"9398536","DOI":"10.1155\/2019\/9398536","article-title":"Public awareness about antibiotic use and resistance among residents in Highland areas of Vietnam","volume":"2019","author":"Ha","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e886","DOI":"10.1016\/S2468-2667(22)00250-X","article-title":"Estimating antimicrobial resistance burden in Europe-what are the next steps?","volume":"7","author":"Hassoun-Kheir","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.idc.2019.07.002","article-title":"Antibiotic-resistant community-acquired bacterial pneumonia","volume":"33","author":"Ho","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/microorganisms10071324","article-title":"Phage products for fighting antimicrobial resistance","volume":"10","author":"Huang","year":"2022","journal-title":"Microorganisms"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40168-022-01250-x","article-title":"Antimicrobial resistance in Antarctica: is it still a pristine environment?","volume":"10","author":"Hwengwere","year":"2022","journal-title":"Microbiome"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1038\/s41598-021-86990-w","article-title":"Thymol nanoemulsion promoted broiler chicken's growth, gastrointestinal barrier and bacterial community and conferred protection against Salmonella Typhimurium","volume":"11","author":"Ibrahim","year":"","journal-title":"Sci. Rep."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"847580","DOI":"10.3389\/fvets.2022.847580","article-title":"Dietary eugenol Nanoemulsion potentiated performance of broiler chickens: orchestration of digestive enzymes, intestinal barrier functions and cytokines related gene expression with a consequence of attenuating the severity of E. coli O78 infection","volume":"9","author":"Ibrahim","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.3390\/ani11072027","article-title":"Supplementing garlic Nanohydrogel optimized growth, gastrointestinal integrity and economics and ameliorated necrotic enteritis in broiler chickens using a Clostridium perfringens challenge model","volume":"11","author":"Ibrahim","year":"","journal-title":"Animals"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/ani13050775","article-title":"Prospective application of Nanoencapsulated Bacillus amyloliquefaciens on broiler Chickens' performance and gut health with efficacy against Campylobacter jejuni colonization","volume":"13","author":"Ismail","year":"2023","journal-title":"Animals"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.15386\/mpr-2409","article-title":"Relationship between antibiotic consumption pattern and antibiotic resistance in neonatal sepsis","volume":"96","author":"Karimi","year":"2023","journal-title":"Med. Pharm. Rep."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.4315\/JFP-22-090","article-title":"Antibiotic resistance profile of Listeria monocytogenes recovered from ready-to-eat foods surveyed in South Africa","volume":"85","author":"Kayode","year":"2022","journal-title":"J. Food Prot."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/heapol\/czaa065","article-title":"What are the barriers to implementing national antimicrobial resistance action plans? A novel mixed-methods policy analysis in Pakistan","volume":"35","author":"Khan","year":"2020","journal-title":"Health Policy Plan."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.crmicr.2022.100115","article-title":"Phage therapy in the Covid-19 era: advantages over antibiotics","volume":"3","author":"Khan","year":"2022","journal-title":"Curr. Res. Microb. Sci."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"101574","DOI":"10.1016\/j.cimid.2020.101574","article-title":"Drug resistant tuberculosis: a review","volume":"74","author":"Khawbung","year":"2021","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41579-021-00649-x","article-title":"Antibiotic resistance in the environment","volume":"20","author":"Larsson","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00294-021-01156-5","article-title":"The role of artificial intelligence in the battle against antimicrobial-resistant bacteria","volume":"67","author":"Lau","year":"2021","journal-title":"Curr. Genet."},{"key":"ref38","first-page":"315","article-title":"Antibiotic resistance","volume":"49","author":"Lim","year":"1994","journal-title":"Med J Malaysia"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.7150\/thno.56205","article-title":"Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bsheal.2020.08.003","article-title":"A review of artificial intelligence applications for antimicrobial resistance","volume":"3","author":"Lv","year":"2021","journal-title":"Biosafety Health"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/ijerph16010027","article-title":"Drivers of irrational use of antibiotics in Europe","volume":"16","author":"Machowska","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.2147\/IJN.S200253","article-title":"Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach","volume":"14","author":"Mahmoodi Chalbatani","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fitd.2022.805833","article-title":"Marks Florian. Measuring the link between vaccines and antimicrobial resistance in low resource settings \u2013 limitations and opportunities in direct and indirect assessments and implications for impact studies","author":"Marianne","year":"2022","journal-title":"Front. Trop. Dis."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1021\/acsinfecdis.2c00649","article-title":"CRISPR-Cas-based antimicrobials: design, challenges, and bacterial mechanisms of resistance","volume":"9","author":"Mayorga-Ramos","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e01908","DOI":"10.1128\/AEM.01908-18","article-title":"Rapid parallel evolution of azole fungicide resistance in Australian populations of the wheat pathogen Zymoseptoria tritici","volume":"85","author":"McDonald","year":"2019","journal-title":"Appl. Environ. Microbiol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e00644","DOI":"10.1128\/mBio.00644-19","article-title":"Diversification of colonization factors in a multidrug-resistant Escherichia coli lineage evolving under negative frequency-dependent selection","volume":"10","author":"McNally","year":"2019","journal-title":"MBio"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41579-020-00506-3","article-title":"The role of vaccines in combatting antimicrobial resistance","volume":"19","author":"Micoli","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.11124\/JBISRIR-2017-003919","article-title":"Antimicrobial resistance in water in Latin America and the Caribbean: a scoping review protocol","volume":"17","author":"Moreno-Switt","year":"2019","journal-title":"JBI Database System Rev. Implement. Rep."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1684\/mst.2017.0678","article-title":"Emergence and spread of antibiotic resistance in West Africa: contributing factors and threat assessment","volume":"27","author":"Ouedraogo","year":"2017","journal-title":"Med. Sante Trop."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1111\/bph.15972","article-title":"Small interfering RNA: discovery, pharmacology and clinical development-an introductory review","volume":"180","author":"Ranasinghe","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ijid.2022.07.018","article-title":"Antimicrobial resistance patterns in bacteria causing febrile illness in Africa, South Asia, and Southeast Asia: a systematic review of published etiological studies from 1980-2015","volume":"122","author":"Roberts","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3389\/fimmu.2020.01048","article-title":"Vaccines against antimicrobial resistance","volume":"11","author":"Rosini","year":"2020","journal-title":"Front. Immunol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.2147\/IJN.S24805","article-title":"Antimicrobial applications of nanotechnology: methods and literature","volume":"7","author":"Seil","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"877845","DOI":"10.3389\/fimmu.2022.877845","article-title":"Prospects on repurposing a live attenuated vaccine for the control of unrelated infections","volume":"13","author":"Seo","year":"","journal-title":"Front. Immunol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14787210.2021.1951705","article-title":"Antimicrobial resistance in low- and middle-income countries: current status and future directions","volume":"20","author":"Sulis","year":"2022","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S1473-3099(18)30648-0","article-title":"Public health burden of antimicrobial resistance in Europe","volume":"19","author":"Tacconelli","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2018.01068","article-title":"Changing priorities in vaccinology: antibiotic resistance moving to the top","volume":"9","author":"Tagliabue","year":"2018","journal-title":"Front. Immunol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"i18","DOI":"10.1093\/jac\/dkac213","article-title":"Country data on AMR in Pakistan in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome","volume":"77","author":"Torumkuney","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1007\/s11033-023-08557-4","article-title":"Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics","volume":"50","author":"Usman","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","volume":"7","author":"Vestergaard","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13756-022-01054-6","article-title":"Antibiotic-resistance in medically important bacteria isolated from commercial herbal medicines in Africa from 2000 to 2021: a systematic review and meta-analysis","volume":"11","author":"Walusansa","year":"2022","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3390\/ijms21031061","article-title":"Defeating antibiotic-resistant Bacteria: exploring alternative therapies for a post-antibiotic era","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref63","year":"2023"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"100521","DOI":"10.1016\/j.lanwpc.2022.100521","article-title":"Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia","volume":"27","author":"Wozniak","year":"2022","journal-title":"Lancet Reg Health West Pac."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coviro.2021.11.001","article-title":"Phage therapy for secondary bacterial infections with COVID-19","volume":"52","author":"Wu","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e0170721","DOI":"10.1128\/mBio.01707-21","article-title":"Bacterial outer membrane vesicles as a versatile tool in vaccine research and the fight against antimicrobial resistance","volume":"12","author":"Zhu","year":"2021","journal-title":"MBio"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1270018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T03:51:14Z","timestamp":1701316274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2023.1270018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":66,"alternative-id":["10.3389\/fmicb.2023.1270018"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2023.1270018","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"article-number":"1270018"}}